Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

Insulin pump market growth is propelled by advancements in technology, rising global diabetes prevalence, and increased demand for precision diabetes management.New Delhi, Feb. 06, 2025 (GLOBE ...

Tambe said the company, a subsidiary of the Bengaluru-based Biocon Ltd, has five products in the pipeline for launch in the ...

Researchers have determined that in comparison to insulin treatment, the use of a strategy of oral glucose-lowering agents ...

Lance Bass gave a health update to PEOPLE, sharing that his diabetes is “finally under control” and he’s been "experimenting" ...

Dr Samet Sahin from the School of Engineering has received £406,000 funding to develop a simple tool to allow healthcare professionals to quickly and ...

The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...

Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.

Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...

GDM is managed with medical nutritional therapy (MNT), exercise, and therapy with human or synthetic insulin. The American Diabetes Association recommends starting insulin therapy when MNT fails ...

Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...